Columbus Circle Investors’s Amedisys AMED Stock Holding History

Columbus Circle Investors’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	$6.84M	Sell	23,313 -9,097	-28%	-$2.33M	0.3%	102
2020 Q3	$7.66M	Sell	32,410 -2,853	-8%	-$649K	0.33%	100
2020 Q2	$7M	Sell	35,263 -39,451	-53%	-$7.36M	0.28%	117
2020 Q1	$13.7M	Sell	74,714 -27,190	-27%	-$4.84M	0.75%	47
2019 Q4	$17M	Buy	101,904 +45,771	+82%	+$6.81M	0.73%	44
2019 Q3	$7.35M	Sell	56,133 -24,771	-31%	-$3.22M	0.27%	120
2019 Q2	$9.82M	Sell	80,904 -9,043	-10%	-$1.07M	0.26%	103
2019 Q1	$11.1M	Buy	89,947 +46,328	+106%	+$5.81M	0.28%	98
2018 Q4	$5.11M	Buy	+43,619	New	+$5.14M	0.14%	117
2017 Q1	–	Sell	-17,294	Closed	-$737K	–	272
2016 Q4	$737K	Sell	17,294 -15	-0.1%	-$638	0.01%	242
2016 Q3	$821K	Sell	17,309 -162	-0.9%	-$8.08K	0.01%	260
2016 Q2	$882K	Buy	17,471 +10,911	+166%	+$551K	0.01%	232
2016 Q1	$317K	Sell	6,560 -16,685	-72%	-$644K	﹤0.01%	256
2015 Q4	$914K	Buy	+23,245	New	+$930K	0.01%	258

Other funds holding AMED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Columbus Circle Investors's AMED Position: Q4 2020 in Review

Columbus Circle Investors reduced its Amedisys (AMED) stake by 28% in Q4 2020, selling an estimated $2.33M and leaving 23,313 shares worth $6.84M. The position accounts for 0.3% of the portfolio, ranked #102.

Columbus Circle Investors first reported a position in AMED in Q4 2015 and has held it in 14 quarters since. The position peaked at $17M in Q4 2019. 398 funds tracked by Wall St. Rank hold AMED as of Q4 2020.

Columbus Circle Investors held 23,313 shares of Amedisys worth $6.84M as of Q4 2020.
Columbus Circle Investors sold 9,097 Amedisys shares in Q4 2020, an estimated $2.33M.
Amedisys made up 0.3% of Columbus Circle Investors's portfolio in Q4 2020, its #102 holding.
Columbus Circle Investors first reported a position in Amedisys in Q4 2015 and has held it in 14 quarters since.
Columbus Circle Investors's Amedisys position peaked at $17M in Q4 2019.
398 funds tracked by Wall St. Rank held Amedisys as of Q4 2020.

Based on Columbus Circle Investors's 13F filing for Q4 2020, filed 20 Jan 2021.